A therapeutic agent derived from oxidized Streptolysin O, intended to treat chronic traumatic brain injury by modulating the inflammatory response and potentially reversing chronic effects.

A multi-component compound designed to alleviate pain and fatigue in patients with hypermobile Ehlers-Danlos Syndrome, a connective tissue disorder, through the synergistic action of low concentrations of biological molecules.